Tweetovi
- Tweetovi, trenutna stranica.
- Tweetovi i odgovori
- Medijski sadržaj
Blokirali ste korisnika/cu @AtrivaTx
Jeste li sigurni da želite vidjeti te tweetove? Time nećete deblokirati korisnika/cu @AtrivaTx
-
“.
@AtrivaTx is working on ways to block viral activity. Dr. Lichtenberger, CEO, told@pharmaphorum that the company’s approach involved inhibiting the pathway which is used by RNA viruses like#coronavirus when they replicate within cells.”https://twitter.com/pharmaphorum/status/1224296980794482688 …
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Atriva Therapeutics proslijedio/la je Tweet
How credible do you think the current reports regarding the Novel
#Coronavirus Acute Respiratory Disease?Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
As the
#coronavirus spreads, fear is fueling racism and#xenophobia - CNN. This is not the they. We need to fight#together and not against each other.https://www.cnn.com/2020/01/31/asia/wuhan-coronavirus-racism-fear-intl-hnk/index.html …Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Atriva Therapeutics proslijedio/la je Tweet
China initially put secrecy and order ahead of confronting the coronavirus. The New York Times reconstructed the crucial 7 weeks when it grew into a crisis.https://nyti.ms/2UfaGP6
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Knowledge and science have no borders. Scientist and experts off all world are working together to find a solution to beat
#2019nCoV. Germans scientist are also contributing working and sharing results.#UnityIsStrength#coronaviruspic.twitter.com/qXeIvXmplt
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Die von .
@AtrivaTx entwickelte Substanz blockiert die Kommunikation zwischen Viren und Körperzellen und kann so effektiv gegen ein breites Spektrum von Viren eingesetzt werden. Atriva ist es gelungen, die Vermehrung von SARS und eines#Coronavirus in Zellkulturen zu verhindern.https://twitter.com/Tagblatt/status/1222751630036291585 …Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Prof. Ludwig ist ein großartiger Wissenschaftler und Kollaborator. Seit Jahren arbeiten wir erfolgreich mit ihm zusammen, um
#ATR002 gegen#flu zu entwickeln.https://twitter.com/UK_Muenster/status/1222537013590745091 …
0:39Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Atriva Therapeutics proslijedio/la je Tweet
Atriva Fast Tracks Antiviral Candidate As Coronavirus Arrives In Germany http://bit.ly/36B3wY6
#PharmaScripHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
The world is under virus attack, but German scientists are already on the move.
@Tagesspiegel spoke with Prof. Dr. Ludwig, developer of@AtrivaTx’ host-targeting#antiviral candidate,#ATR002, about pandemic threats like#flu, SARS, MERS and#coronavirus. https://bit.ly/2O7CMrK pic.twitter.com/fT8OSsdVdv
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
The 3rd and last conference during the
@AtrivaTx’s San Francisco tour is the 15th Non-Dilutive Funding Summit@FreemindGrp. Meet our representatives to learn more about our potential in the development of host-targeting#antiviral therapies.#fightflu https://bit.ly/2QxOJs6 pic.twitter.com/tE26ECUJ8L
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
We look forward to telling you more about
#ATR002, our host-targeting approach to treat#flu, at the RESI conference, where 500+ early stage investors gather every year. Dr. Rainer Lichtenberger will present Atriva during the track 4, 8:00 am.@LSciNation https://bit.ly/2N0MUlh pic.twitter.com/is4vr7crmV
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Atriva Therapeutics proslijedio/la je Tweet
'Good Morning from
#BiotechShowcase 2020!@MCServicesAG is on site in San Francisco, excited for three days of presentations, panels and 1X1 meetings at one of the industry's leading investor conferences. We're looking forward to meeting you! https://bit.ly/2OSQ3UE@EBDgrouppic.twitter.com/EgzREu3Bza
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Learn more about
@AtrivaTx’s host-targeting therapy candidate#ATR002 against#flu, hanta and further severe respiratory viral infections at the company presentation of our CEO, Dr. Lichtenberger, today at#BiotechShowcase. Join us at 11:30, Franciscan D. https://bit.ly/39PxxWE pic.twitter.com/4C0P2MzBMb
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
@AtrivaTx kicks off the new year by travelling to#SanFrancisco to participate in three conferences. Dr. Lichtenberger, CEO, Dr. Wallasch, COO, and Dr. Björn Cochlovius, VP BD, will represent the Company and be available for networking and one-on-ones. https://bit.ly/36C8vbR pic.twitter.com/85h9KnIn4X
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Atriva Therapeutics proslijedio/la je Tweet
During this holiday season relax and enjoy the time with family and friends and don't forget to register for
#BiotechShowcase in#SanFrancisco: January 13-15, 2020. .@MCServicesAG will be on site to support you! We hope to see you there! https://bit.ly/2OSQ3UE pic.twitter.com/27vxoLRQvQ
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
#Flu is always lurking, especially during the winter season, which impairs our immune system. At@AtrivaTx, we are developing a unique portfolio of broadly active and efficacious antiviral drugs. Stay warm and enjoy the#holidays.#MerryChristmas and#HappyNewYear from Atriva.pic.twitter.com/tX6m2UEZbv
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
#Congrats!@AtrivaTx’s co-founder and scientific advisor Prof. Ludwig, head of the Virology Institute at@WWU_Muenster is prominently featured in an interesting article on the#flu by@FAZ_NET: https://bit.ly/2sHonKS .#fightflu#innovation#ATR002#medicalneed@faznetpic.twitter.com/VGqIfflNW9
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Atriva Therapeutics proslijedio/la je Tweet
.
@MCServicesAG invites journalists to attend#BiotechShowcase 2020. We will be on site to support media and partnering meetings and to organize interviews. Do not hesitate to contact us. See you in San Francisco! https://bit.ly/2OSQ3UE pic.twitter.com/bPj9ZG8fCR
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
@AtrivaTx’s strategy and product candidate#ATR002 “may revolutionize treatment of#influenza and other severe respiratory viral infections” and be “a quantum leap in#antiviral respiratory therapies”. Learn more in the article by@bpdealmakers https://go.nature.com/2KDTqh0 pic.twitter.com/ATH2tiKcVY
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Learn more about
#MEKinhibitors against#influenza and respiratory#viralinfections in the presentation of Dr. Rainer Lichtenberger, our CEO, today at 5.45 PM during the “Infectious Disease Company Presentations” section Level 1/Hall B1/Room 7#BIOEurope https://bit.ly/33TyLg4 pic.twitter.com/Q0I6A2NXoh
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi
Čini se da učitavanje traje već neko vrijeme.
Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.
Zum ausführlichen Interview: